Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Blood processing is a technique required to prepare and identify the blood and blood products, to check their suitability for therapeutic, prophylactic or other in-vivo or in-vitro purposes. Blood processing devices and consumables are widely used in the storage, dispensation, and administration of donated blood. Several blood storage and extraction devices such as blood bags, lancets, freezers, and refrigerators are used for the storage of large amount of blood for extended period. Furthermore, blood processing devices and such as cell processors, laboratory equipment, and haematology reagents, are typically used to inspect the donated blood for the presence of a variety of haematological aberrations and blood-borne diseases.
The global blood processing devices and consumables market has gained remarkable growth owing to increasing aging population and rise in diseases related to blood transfusion. Continuing research and studies demonstrating positive results is widening the scope of blood processing devices and consumables for the diagnosis and treatment of diseases. Moreover, introduction of innovative blood processing devices in the market coupled with favourable reimbursement policies are fuelling the market growth. The market is further boosted by development in the production of processing devices and consumables. However, the global blood processing devices and consumables market is hampered by lack of blood processing infrastructure in low-income countries and severe regulatory guidelines. Moreover, high capital investment and steep operational costs are also creating an aversion among vendors of blood processing devices and consumables.
The report analyses the global blood processing devices and consumables market based on blood processing devices, consumables, end users and geography.
The various blood processing devices are presented as blood bank freezers, blood warmers, blood grouping analysers, blood bank refrigerators, haematocrit centrifuges and blood cell processors. The demand for automated blood processing devices is higher in the market due to their improved accuracy, faster activity, result delivery, and specificity. At present, haematocrit centrifuges and blood cell processors are the largest revenue generating segment due to technological advancement in laboratory devices. Whereas, the blood processing consumers are blood lancets, coagulation and blood grouping reagents, blood filters vials, blood collection tubes and needles, microscopic slides and strainers, blood administration sets, blood bags, sedimentation tubes and haematology reagents.
Consumables required for the process of blood processing area blood lancets, coagulation and blood grouping reagents, blood filters vials, blood collection tubes and needles, microscopic slides and strainers, blood administration sets, blood bags, sedimentation tubes and haematology reagents. The consumables are expected to record momentous growth in the coming years due to significant advancement such as the introduction of in-built filters in plasma collection tubes. Additionally, sedimentation tubes and haematology reagents are anticipated to flourish at a lucrative rate during the forecast period owing to the innovations in point-of-care haematology testing services and subsequent increase in consumables market usage
Hospitals and blood banks are the major end users of this market, due to upsurge in several storage banks in developing as well as developed economies and presence of considerable government funding for research to develop fully automatic devices.
The global blood processing devices and consumables market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to account for the largest share in 2017, followed by Europe and Asia-Pacific. Factors such as presence of sophisticated healthcare infrastructure, prominent industry entities, and strong government support are fuelling the growth in North America. In addition to this, the demand for blood processing devices and consumables is increasing in emerging markets such as China and India due to expanding population bases coupled with increasing epidemic of infectious diseases. The Asia-Pacific region is expected to grow at a lucrative growth rate during the forecast period. This high growth can be attributed to rising awareness regarding blood donation and safe transfusion procedures due to favorable government and private campaigns.
Some of the major entities operating in the blood processing devices and consumables market include Abbott Laboratories, Becton Dickinson and Company, Beurer GmbH, BioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, Grifols International, Haemonetics Corporation, Immucor, Inc., Macopahrma SA, Roche Holdings AG and Terumo Corporation among others. New product launches and endorsements are the key growth strategies adopted by major players to reinforce their positions in the international market. Moreover, strategies such as expansions, as well as partnerships were also implemented by numerous market players to expand their R&D competences and geographic presence in the global market
February 2018: Cesca Therapeutics introduces AXP II System for the advanced isolation, collection and storage of hematopoietic stem cell concentrates from cord blood and peripheral blood. With the commercial launch of AXP II, company continued to provide the innovative products to the cord blood bank market.
November 2018: Orgenesis Inc a manufacturer of advanced cell therapies, entered into a collaboration agreement with the New York Blood Center (NYBC), one of the largest independent, community-based blood centers in the world. Under the agreement, NYBC will be responsible for establishing the infrastructure to collect, process, test, cryopreserve and biobank sampling materials, including liver biopsies.
The report analyses the global blood processing devices and consumables market based on blood processing devices, consumables, end users and geography.
The various blood processing devices are presented as blood bank freezers, blood warmers, blood grouping analysers, blood bank refrigerators, haematocrit centrifuges and blood cell processors. The demand for automated blood processing devices is higher in the market due to their improved accuracy, faster activity, result delivery, and specificity.
Consumables required for the process of blood processing area blood lancets, coagulation and blood grouping reagents, blood filters vials, blood collection tubes and needles, microscopic slides and strainers, blood administration sets, blood bags, sedimentation tubes and haematology reagents. The major end users of the market are hospitals and blood bank.
The global blood processing devices and consumables market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Some of the major entities operating in the blood processing devices and consumables market include Abbott Laboratories, Becton Dickinson and Company, Beurer GmbH, BioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, Grifols International, Haemonetics Corporation, Immucor, Inc., Macopahrma SA, Roche Holdings AG and Terumo Corporation among others
Why to buy this report:
